Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.
Momenta Pharmaceuticals Inc (Momenta) announced that it has entered into a definitive agreement with Johnson & Johnson (J&J). According to the agreement, J&J will acquire Momenta for USD 52.50 per share in an all-cash transaction.
Industry needs to have a transparency to gain the patient trust and awareness needs to be created through all channels and platforms said by Prof. Kiran Kalia, Director, NIPER, Ahmedabad.
US Food & Drug Administration (US FDA) has approved the Abbreviated New Drug Application (ANDA) filed by Granules Pharmaceuticals, Inc (GPI)., a wholly owned foreign subsidiary of Granules India Limited for Ramelteon Tablets, 8 mg.
WHO working with CCRH, Ministry of AYUSH, GoI for working on the education standards and benchmark in Homeopathy colleges and CCRH and there is a need to allow adjuvant treatment of Homeopathy with Modern Medicine for Covid 19.
Rs. 4000 cr sanctioned to NMPB, Ministry of AYUSH, Govt. of India to make medicinal plants & herbs better and cheaper and will double income of farmers and there is a need to link our education system to knowledge of AYUSH.
Biological E. Limited (BE), a Hyderabad-based pharmaceuticals & Biologics company, announced the acquisition of Akorn India Limited, a subsidiary of Akorn Inc., USA.
CLICK HERE TO SUBSCRIBE,
PHARMATUTOR's DAILY EMAILS
Do Not Forget to Verify
(Click on Subscription link in your inbox)
--------
